Opioid Distributor, 2 Execs Are Charged, Plead Or Settle Conspiracy, Fraud Claims

(April 24, 2019, 1:39 PM EDT) -- NEW YORK — In what a U.S. attorney described as a first-of-its-kind action, the United States on April 23 secured a consent decree and a $20 million penalty from a pharmaceutical...
To view the full article, register now.